Applicants must first apply for other supplement funding opportunities such as NIH continuity supplement NOT-OD-20-054, SCORE and the DOM supplemental award,
if they are eligible. Priority will be given to Ludeman Center scientists who have not received supplement funding through these and other mechanisms when awarding the Ludeman Center supplemental award.
The purpose of this award is to provide a mechanism
of support for early-career scientists whose research careers have been affected by COVID-19. The Ludeman Center supplemental awards are one-year grants, not to exceed $15,000, for exceptional faculty members and fellows conducting research focused
on women’s health or sex/gender differences in the underlying mechanisms, diagnosis, treatment, or management of CVD, diabetes, and/or mental health as it relates to physical health. Research focused on other diseases or physiological questions
will be considered relevant if there is a connection to CVD, diabetes or the intersection of physical and mental health on these diseases (e.g. cardiovascular complications of rheumatoid arthritis, oral health as it relates to CVD, etc.).
Because the long-term goal of this award is to enable a researcher to pursue a research career in women’s health and/or sex/gender differences, priority for this award is reserved for fellows and early-career faculty applicants. However, mid–level and senior faculty will be considered if there is a clear reason why this type of funding would provide benefit to their research careers.
Applications are due Tuesday, June 15, 2021, by 5:00 p.m. MT with the anticipated start of the funding period in August 2021.